Effect of green coffee poly cystic ovary syndrome

Phase 3

Recruiting

Conditions: Polycystic ovary syndrome.
Polycystic ovarian syndrome
E28.2

Registration Number: IRCT20191129045540N1

Lead Sponsor: Tehran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 40

Inclusion Criteria

Women with polycyctic ovary syndrom who tend to participate in research
Age range of 20-40 years old

Exclusion Criteria

Pregnancy decision during the study period
Having a allergy and intolerance to Green Coffee supplement
Taking steroidal and non-steroidal anti-inflammatory drugs
The precence of thyroid and kidney disorders
Consumption of nutritional supplement other than calcium, iron and folic acid

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Paraoxonase-1 level. Timepoint: At the begining and at the end of the study (after 40 days). Method of measurement: ELISA.;Malondialdehyde level. Timepoint: At the begining and at the end of the study (after 40 days). Method of measurement: ELISA.

Secondary Outcome Measures

Name	Time	Method
Cholestrol. Timepoint: At the beginning of and at the end of study (after 40 days). Method of measurement: Auto Anelyzer.;Triglycerid. Timepoint: At the begining and at the end of study (after 40 days). Method of measurement: Auto anelyzer.;LDL. Timepoint: At the begining and at the end of study(after 40 days). Method of measurement: Auto anelyzer.;HDL. Timepoint: At the begining and at the end of study(after 40 days). Method of measurement: Auto anelyzer.;Fasting blood glucose. Timepoint: At the begining and at the end of study(after 40 days). Method of measurement: Auto anelyzer.;Insulin. Timepoint: At the begining and at the end of study(after 40 days). Method of measurement: Elisa.